Avanzanite Bioscience

Avanzanite Bioscience company information, Employees & Contact Information

Founded by biopharmaceutical executives, Adam Plich and Anant Murthy, Avanzanite is on a mission to redefine the commercialization of orphan medicines to improve patient access across Europe and beyond. Derived from the word ‘Tanzanite’ – one of the rarest and most underappreciated gemstones on earth – Avanzanite was formed to capitalize on two primary objectives, one economic, and one humanitarian. The economic goal is to offer end-to-end commercialization and distribution partnerships with research-based biopharmaceutical originators to unlock the full value of their orphan medicines in European markets. This is the unique expertise and core competency of our team following decades of operating experience navigating this area. Equally important, our humanitarian goals stem from our commitment to enabling access to novel medicines for patients who suffer from orphan diseases regardless of where in Europe they live. Avanzanite Bioscience B.V. is a fully authorized distributor of medicinal products within the European Economic Area, Switzerland and the UK, with a Wholesale Distributor Authorization (WDA) issued by Farmatec in the Netherlands.

Company Details

Employees
43
Founded
-
Address
Strawinskylaan 3051, Amsterdam,north Holland 1077 Zx,netherlands
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Amsterdam, North Holland
Looking for a particular Avanzanite Bioscience employee's phone or email?

Avanzanite Bioscience Questions

News

Avanzanite Bioscience’s Partner Agios Announces Positive CHMP Opinion for PYRUKYND® (mitapivat) for Adults with Thalassemia - Business Wire

Avanzanite Bioscience’s Partner Agios Announces Positive CHMP Opinion for PYRUKYND® (mitapivat) for Adults with Thalassemia Business Wire

Avanzanite Expands Italian Operations with General Manager Appointment - galvnews.com

Avanzanite Expands Italian Operations with General Manager Appointment galvnews.com

Avanzanite Bioscience Welcomes Dr. Mark Bechter as SVP Medical Affairs - afp.com

Avanzanite Bioscience Welcomes Dr. Mark Bechter as SVP Medical Affairs afp.com

Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND in Rare Blood Disorders - Business Wire

Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND in Rare Blood Disorders Business Wire

Avanzanite Bioscience Appoints Sotiris Botozis as General Manager Southern Europe - FinancialContent

Avanzanite Bioscience Appoints Sotiris Botozis as General Manager Southern Europe FinancialContent

Avanzanite Bioscience Appoints Chief Financial Officer - FinancialContent

Avanzanite Bioscience Appoints Chief Financial Officer FinancialContent

Avanzanite Bioscience Announces Appointment of Chief Technical Officer to Accelerate European Expansion and Drive Growth - Business Wire

Avanzanite Bioscience Announces Appointment of Chief Technical Officer to Accelerate European Expansion and Drive Growth Business Wire

Avanzanite Bioscience Reports European Commission's Authorisation of Orphan Medicinal Product AKANTIOR - Business Wire

Avanzanite Bioscience Reports European Commission's Authorisation of Orphan Medicinal Product AKANTIOR Business Wire

Received Positive CHMP Opinion and Announces Corporate Expansion Into 26 European Countries - Business Wire

Received Positive CHMP Opinion and Announces Corporate Expansion Into 26 European Countries Business Wire

Avanzanite Bioscience Expands Partnership With Advicenne in Additional European Countries - Business Wire

Avanzanite Bioscience Expands Partnership With Advicenne in Additional European Countries Business Wire

For the Treatment of Rare Kidney Disease in Germany, Austria, Switzerland and Greece - Business Wire

For the Treatment of Rare Kidney Disease in Germany, Austria, Switzerland and Greece Business Wire

Avanzanite Bioscience Launches Novel Business Model to Commercialize Innovative Medicines for Rare Diseases in Europe - Business Wire

Avanzanite Bioscience Launches Novel Business Model to Commercialize Innovative Medicines for Rare Diseases in Europe Business Wire

Top Avanzanite Bioscience Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant